PL369498A1 - Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek - Google Patents

Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek

Info

Publication number
PL369498A1
PL369498A1 PL02369498A PL36949802A PL369498A1 PL 369498 A1 PL369498 A1 PL 369498A1 PL 02369498 A PL02369498 A PL 02369498A PL 36949802 A PL36949802 A PL 36949802A PL 369498 A1 PL369498 A1 PL 369498A1
Authority
PL
Poland
Prior art keywords
infected cells
poxviruses
recovery
virus
purification
Prior art date
Application number
PL02369498A
Other languages
English (en)
Other versions
PL205929B1 (pl
Inventor
Karl Heller
Jutta Kramer
Original Assignee
Bavarian Nordic A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bavarian Nordic A/S filed Critical Bavarian Nordic A/S
Publication of PL369498A1 publication Critical patent/PL369498A1/pl
Publication of PL205929B1 publication Critical patent/PL205929B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Plant Substances (AREA)
PL369498A 2001-12-20 2002-12-13 Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek PL205929B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101928 2001-12-20

Publications (2)

Publication Number Publication Date
PL369498A1 true PL369498A1 (pl) 2005-04-18
PL205929B1 PL205929B1 (pl) 2010-06-30

Family

ID=8160920

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369498A PL205929B1 (pl) 2001-12-20 2002-12-13 Sposób odzyskiwania i oczyszczania poxywirusów z zainfekowanych komórek

Country Status (22)

Country Link
US (1) US7056723B2 (pl)
EP (1) EP1407006B9 (pl)
JP (2) JP5322252B2 (pl)
KR (1) KR100947976B1 (pl)
CN (1) CN1289663C (pl)
AT (1) ATE302268T1 (pl)
AU (1) AU2002352247B2 (pl)
BR (1) BRPI0215003B1 (pl)
CA (1) CA2467099C (pl)
DE (1) DE60205631T2 (pl)
DK (1) DK1407006T3 (pl)
EA (1) EA006485B1 (pl)
ES (1) ES2247404T3 (pl)
HU (1) HU227507B1 (pl)
IL (2) IL161526A0 (pl)
MX (1) MXPA04006001A (pl)
NO (1) NO335975B1 (pl)
NZ (1) NZ533586A (pl)
PL (1) PL205929B1 (pl)
SI (1) SI1407006T1 (pl)
UA (1) UA77735C2 (pl)
WO (1) WO2003054175A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
WO2002042480A2 (en) 2000-11-23 2002-05-30 Bavarian Nordic A/S Modified vaccinia ankara virus variant
SI1434858T2 (sl) * 2002-09-05 2019-05-31 Bavarian Nordic A/S Postopek za pomnoževanje poksvirusa v razmerah brez seruma
US7951576B2 (en) * 2004-11-05 2011-05-31 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for preparing cells and viruses
US7625570B1 (en) * 2005-03-10 2009-12-01 The Regents Of The University Of California Methods for purifying adeno-associated virus
AU2008250596C1 (en) * 2007-05-14 2010-11-25 Bavarian Nordic A/S Purification of Vaccinia virus- and recombinant Vaccinia virus-based vaccines
US8003363B2 (en) 2007-05-14 2011-08-23 Bavarian Nordic A/S Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
BRPI0908474A2 (pt) * 2008-02-12 2016-07-26 Sanofi Pasteur Ltd métodos de uso de cromatografia de troca de íon e de filtração de gel para purificação de vírus causador da catapora
SG176554A1 (en) * 2009-05-12 2012-01-30 Transgene Sa Method for orthopoxvirus production and purification
FR2953686B1 (fr) * 2009-12-14 2012-11-02 Agronomique Inst Nat Rech Procede pour reduire la teneur bacterienne d'un milieu alimentaire et/ou biologique d'interet, contenant des gouttelettes lipidiques
US10087423B2 (en) 2010-07-20 2018-10-02 Bavarian Nordic A/S Method for harvesting expression products
CN102353792A (zh) * 2011-07-07 2012-02-15 贵州大学 一种基于gpv p32蛋白的间接elisa试剂盒及制备方法
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
KR20200003921A (ko) 2017-05-15 2020-01-10 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스-함유 조성물
WO2018211419A1 (en) 2017-05-15 2018-11-22 Janssen Vaccines & Prevention B.V. Stable virus-containing composition
EP3847246A1 (en) 2018-09-06 2021-07-14 Bavarian Nordic A/S Storage improved poxvirus compositions
EP4117722A1 (en) 2020-03-12 2023-01-18 Bavarian Nordic A/S Compositions improving poxvirus stability
EP4547273A1 (en) 2022-06-29 2025-05-07 Bavarian Nordic A/S Recombinant modified sarna (vrp) and vaccinia virus ankara (mva) prime-boost regimen
CN119604618A (zh) 2022-06-29 2025-03-11 巴法里安诺迪克有限公司 爱泼斯坦-巴尔病毒疫苗
CN115197966A (zh) * 2022-08-15 2022-10-18 深圳源兴基因技术有限公司 一种利用生物反应器大规模生产重组痘苗病毒载体的方法
FR3160186A1 (fr) 2024-03-13 2025-09-19 Odimma Therapeutics Vecteur non-viral pour transcription augmentee

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB877898A (en) 1956-12-06 1961-09-20 Apv Co Ltd A new or improved method of liberating enzymes
JPS5328989B2 (pl) 1974-05-27 1978-08-17
CH621573A5 (en) 1976-08-05 1981-02-13 Vnii Biosinteza Belkovykh Vesc Process for the continuous disintegration of microorganism cells and system for carrying out this process
JPS54154594A (en) 1978-05-25 1979-12-05 Sumitomo Chem Co Ltd Extraction of glucose isomerase
WO1991001367A1 (en) 1989-07-20 1991-02-07 Bioeng, Inc. Supercritical fluid disruption of and extraction from microbial cells
UA68327C2 (en) * 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
TW426733B (en) 1995-10-06 2001-03-21 Merck & Co Inc Method of disrupting cultured cells using an impinging jet device
WO1998013500A2 (en) * 1996-09-24 1998-04-02 Bavarian Nordic Research Institute A/S Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
US5721120A (en) 1996-10-02 1998-02-24 Merck & Co., Inc. Method of disrupting cultured cells using an impinging jet device
NZ299720A (en) * 1996-11-08 1999-07-29 Howick Engineering Ltd Epicyclic input/output annuli of same pcd, with planetary input/output gear sets, and with only one set having aligned teeth
BR9713368A (pt) * 1996-11-20 2001-09-18 Introgen Therapeutics Inc Processo melhorado para a produção e a purificação de vetores adenovirais
US6000551A (en) 1996-12-20 1999-12-14 Eastman Chemical Company Method for rupturing microalgae cells
FR2787465A1 (fr) * 1998-12-21 2000-06-23 Transgene Sa Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
WO2000050573A1 (fr) * 1999-02-22 2000-08-31 Transgene S.A. Procede d'obtention d'une preparation virale purifiee
DE19918619A1 (de) 1999-04-23 2000-10-26 Rhein Biotech Proz & Prod Gmbh Verfahren zum Gewinnen von rekombinantem HBsAg
US6951752B2 (en) * 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen

Also Published As

Publication number Publication date
EA006485B1 (ru) 2005-12-29
DE60205631T2 (de) 2006-06-08
EP1407006B1 (en) 2005-08-17
AU2002352247B2 (en) 2008-08-07
IL161526A (en) 2009-11-18
HUP0402337A3 (en) 2010-01-28
KR20040070263A (ko) 2004-08-06
US7056723B2 (en) 2006-06-06
AU2002352247A1 (en) 2003-07-09
DE60205631D1 (de) 2005-09-22
NZ533586A (en) 2005-02-25
NO20043181L (no) 2004-07-19
JP5322252B2 (ja) 2013-10-23
CN1606616A (zh) 2005-04-13
EP1407006B9 (en) 2006-10-18
CA2467099C (en) 2013-01-29
ES2247404T3 (es) 2006-03-01
CN1289663C (zh) 2006-12-13
SI1407006T1 (sl) 2006-04-30
UA77735C2 (en) 2007-01-15
IL161526A0 (en) 2004-09-27
CA2467099A1 (en) 2003-07-03
WO2003054175A1 (en) 2003-07-03
KR100947976B1 (ko) 2010-03-15
ATE302268T1 (de) 2005-09-15
US20040265986A1 (en) 2004-12-30
HU227507B1 (hu) 2011-07-28
HUP0402337A2 (hu) 2005-01-28
JP2010046093A (ja) 2010-03-04
BR0215003A (pt) 2004-11-09
BRPI0215003B1 (pt) 2017-03-14
MXPA04006001A (es) 2005-08-19
DK1407006T3 (da) 2005-12-12
NO335975B1 (no) 2015-04-07
PL205929B1 (pl) 2010-06-30
EA200400833A1 (ru) 2004-12-30
HK1071765A1 (en) 2005-07-29
EP1407006A1 (en) 2004-04-14
JP2005512565A (ja) 2005-05-12

Similar Documents

Publication Publication Date Title
IL161526A0 (en) Method for the recovery and purification of poxviruses from infected cells
WO2001064835A8 (en) Novel nucleic acids and polypeptides
NZ600629A (en) Vaccinia virus mutants containing the major genomic deletions of mva
BR0317091A (pt) Processo para preparação de 1-olefinas através da dissociação catalìtica de 1-alcoxialcanos
WO2004029781A3 (en) System for analyzing a capital structure
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
NZ597998A (en) Methods for treating cancer with mva
DE60227268D1 (de) Knockout-mutante von vaccinia-virus und verwendung davon
WO2002016620A3 (en) Modulation of stem cell differentiation
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
NO20040222L (no) Peptider til fjerning eller destruksjon av celler
ATE411974T1 (de) Verfahren zur gewinnung von gereinigtem hydroxytyrosol aus von dem olivenbaum erhaltenen produkten und nebenprodukten
IL199126A (en) Promoters for expression in modified vaccinia virus ankara (mva) and vectors comprising said promoters.
MXPA03007535A (es) Metodo para extraer virus de cultivo celular.
WO2005027836A3 (en) Immunogen
WO2002004544A3 (en) Polymers and polymerization processes
WO2002072803A3 (en) Subgenomic replicons of the flavivirus dengue
DE60302848D1 (de) Expression von genen im modifizierten vaccinia virus ankara durch verwendung eines cowpox ati promoter
FR2849375B1 (fr) Compositions cosmetiques, par exemple pour traiter le vieillissement cutane photo-induit
ATE376365T1 (de) Verfahren zur bearbeitung von ginseng sowie bearbeiteter ginseng erhaeltlich durch dieses verfahren
AU2003277909A1 (en) Recombinant mva strains as potential vaccines against p. falciparum malaria
WO2006052826A3 (en) Methods for preparing cells and viruses
WO2002087499A3 (en) Cells for detection of enteroviruses
BR0015360A (pt) Vernizes não-coloridos, processo para produção dos mesmos e uso dos mesmos
WO2002090550A3 (en) Method for preparing recombinant poxvirus